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This study tested the hypothesis that very late antigen (VLA)-4
mediates CD18-independent neutrophil emigration into the air-




, a stimulus that





, toward which only 20–30% of the total number of
neutrophils emigrate through CD18-independent pathways. In wild-
type (WT) mice, VLA-4 expression was less on neutrophils that em-
igrated into the airspaces than on circulating neutrophils. Vascular
cell adhesion molecule-1 (VCAM-1) mRNA, the major endothelial









 pneumonia. VCAM-1 protein expression was not detected in









 pneumonia was similar
in mice given antibodies against both CD18 and VLA-4 compared
with mice given the anti-CD18 antibody and a control antibody.
However, in hematopoietically reconstituted mice with both WT
and CD18-deficient neutrophils in their blood, the migration of
 





but significantly less in animals pretreated with the anti–VLA-4 an-
tibody than in those receiving a control antibody. These data sug-
gest that VLA-4 plays a small role in CD18-independent neutrophil
emigration, but the majority of CD18-independent neutrophil em-
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Neutrophil emigration out of the bloodstream into sites of in-
flammation is governed by adhesive events involving receptor–
ligand pairs of adhesion molecules on neutrophils and endothe-
lial cells (1, 2). The integrins are a family of cell surface molecules
that mediate cell–cell and cell–extracellular matrix adhesion













2) integrins are het-





2 (CD18) chain and one of four possible CD11 chains




2 integrins are required for acute
neutrophil emigration under most circumstances (1, 5, 6). In
the lungs, however, neutrophil emigration occurs not only via
CD11/CD18-dependent, but also through CD11/CD18-inde-
pendent, pathways (6, 7). The stimulus appears to determine
which adhesion pathway will be selected. Neutrophil emigra-













, phorbol ester, IgG immune
complexes, or interleukin-1 (IL-1) is inhibited by 60–80%
when the function of CD11/CD18 is blocked, implying that
20–40% of neutrophils migrate through CD18-independent
pathways (6). CD18-independent pathways are even more criti-









, hydrochloric acid, hyperoxia,
or C5a complement fragments, where CD18 blockade does
not alter neutrophil emigration at all (6, 7). The adhesion mol-
ecules that mediate the CD18-independent pathways have not
been identified.
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 (very late antigen-4 [VLA-4]; CD49d/CD29) is a
member of this subfamily and is expressed at substantial levels
on mononuclear leukocytes (8–10). Its primary endothelial
cell ligand is vascular cell adhesion molecule-1 (VCAM-1), and
it also recognizes fibronectin (11). VLA-4 has important roles
in monocyte and lymphocyte rolling and adhesion to endothe-
lium. In the lungs, VLA-4 is required for eosinophil and T cell
recruitment in the late-phase response and in airway hyperre-
sponsiveness induced by antigen sensitization and challenge
(8, 12–14).
Recent reports have described the expression of VLA-4 on









. Kubes and colleagues
demonstrate that VLA-4 is upregulated during the process of
transendothelial cell migration in response to formyl-methio-
nyl-leucyl-phenylalanine (fMLP) and anti–VLA-4 antibodies
partially block the CD18-independent adhesion of these emi-
grated neutrophils (15). Neutrophils induced to express VLA-4















, blockade of VLA-4 by specific antibodies completely in-





, or LPS (17). Blockade of VLA-4
attenuates the fraction of neutrophil emigration during adju-
vant-induced arthritis that is not inhibitable by anti-CD18 anti-
bodies, suggesting that VLA-4 can mediate CD18-indepen-
dent neutrophil emigration (17–19).
Very recently, Ridger and colleagues (20) demonstrated




1 integrins (CD29) prevented neutro-
phil emigration in response to either LPS (which evokes pri-
marily CD18-dependent emigration) or KC, a chemokine that
induces CD18-independent emigration. Elegant electron mi-




1 integrins were involved in
the migration of neutrophils from the interstitium to the alve-
olus rather than in neutrophil–endothelial cell adhesion. Fur-










4, VLA-4) were important only in KC-induced
neutrophil emigration, whereas CD49e and CD49f inhibited
responses to both KC and LPS (20). Studies by Burns and col-
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in rats where approximately 80% of the migration still occurs
despite blockade of CD18, and over half of the CD18-inde-
pendent accumulation of neutrophils within the bronchoalve-
olar lavage (BAL) fluid was prevented when VLA-4 was
blocked (21). Both these studies suggest a role for VLA-4 in
CD18-independent neutrophil emigration from the capillaries
to the airspaces.
To elucidate the role of VLA-4 in CD18-independent neu-
trophil emigration during bacterial pneumonia, we examined
the expression of VLA-4 and VCAM-1 on neutrophils and en-
dothelial cells during pneumonia, as well as the role of VLA-4
when the function of CD18 was blocked by either antibodies
or by genetic deficiency. VLA-4 expression was measured on
neutrophils obtained from the bone marrow, circulating blood,
or BAL fluid in wild-type (WT) and CD18-deficient mice.
VCAM-1 mRNA and protein expression was examined using
reverse transcription–polymerase chain reaction (RT-PCR) and
immunohistochemistry. The function of VLA-4 in neutrophil









 pneumonias, where neutrophil emigration oc-
curs through primarily CD18-independent and -dependent path-
ways, respectively. The function of VLA-4 was evaluated during
blockade of CD18 using two distinct approaches. First, the ef-
fect of an anti–VLA-4 antibody was evaluated when CD18-
dependent emigration was blocked using an anti-CD18 antibody.
Second, mice with both CD18-deficient and WT circulating
neutrophils were generated by reconstituting the hematopoie-
tic systems of lethally irradiated C57BL/6 mice with a mixture
of fetal liver cells from WT and CD18-deficient mice. Recruit-





 pneumonia was examined using these
reconstituted mice after pretreatment with either anti–VLA-4




Protocol 1: VLA-4 Expression on Neutrophils
 





 129/Sv), generously provided by Dr. Arthur L. Beaudet
at Baylor College of Medicine, Houston, TX, were anesthetized and

















 colony forming units [CFU]/ml suspension–
5% colloidal carbon) as previously described (22, 23, 25–27). After 6
hours, lungs were lavaged with phosphate-buffered saline (PBS)–0.6
mM ethylenediamine tetraacetic acid (EDTA). Blood samples from
infected and noninfected mice were obtained from the inferior vena
cava, and bone marrow cells were obtained from the femurs. VLA-4
expression was measured by flow cytometry using fluoroscein isothio-





PharMingen, San Diego, CA) and a phycoerythrin (PE)-conjugated
mAb against the murine granulocyte marker Gr-1 (RB6-8C5; Phar-





was used as an isotype control for the anti–VLA-4 antibody.
 
Protocol 2: mRNA and Protein Expression of VCAM-1
during Pneumonia
 

























 CFU/ml) as in
Protocol 1. VCAM-1 mRNA and protein expression were studied 4
and 6 hours later, respectively. Pneumonic and uninfected lungs were
either frozen in liquid nitrogen for total RNA extractions or were in-
flated with Tissue-Tek diluted 1:1 with PBS (0.8 ml/lung) and frozen
for immunohistochemistry.
 
Protocol 3: The Effect of Anti–VLA-4 mAb on Acute 
Inflammation during Pneumonia
 
To determine the role of VLA-4 in CD18-independent neutrophil em-
igration, two groups of C57BL/6 mice (8–12 weeks old, Harlan Spra-
gue–Dawley) were studied. Group 1 was given an intravenous injec-
tion of both anti-CD18 mAb (2E6, 2 mg/kg; Endogen, Woburn, MA)
and anti–VLA-4 mAb (PS/2; 4 mg/kg) 15 minutes before bacterial in-
stillation; Group 2 received anti-CD18 mAb (2E6; 2 mg/kg) and rat
IgG (4 mg/kg) instead of the anti–VLA-4 mAb. The blocking anti-
mouse VLA-4 mAb PS/2 was kindly provided by Dr. C. Wayne Smith





 studies by many investigators (29–34).






































l/22 g bw) as described in Protocol 1. Edema forma-
tion was measured using radioisotopes, and neutrophil emigration
was quantitated morphometrically using histologic sections (23, 25–
27). Circulating leukocyte and neutrophil counts were measured in
blood samples from the inferior vena cava.
 
Protocol 4: Effect of Anti–VLA-4 mAb on CD18-Deficient 
Neutrophil Emigration
 
The percentages of CD18-deficient neutrophils in the circulating and




 pneumonia were compared us-
ing lethally irradiated and reconstituted mice whose bone marrows
were producing both CD18-deficient and WT neutrophils as previ-
ously described (22). At least 2 weeks after cessation of antibiotics,
mice received an intravenous injection of either rat IgG (4 mg/kg) or













 CFU/ml). After 6 hours, the
migration of CD11/CD18-deficient neutrophils into the airspaces was








 standard error of the mean. One-way













VLA-4 Expression on Neutrophils
 
To determine whether VLA-4 expression increased on neutro-
phils that migrated using CD18-independent pathways, VLA-4
expression on neutrophils obtained from either peripheral blood




 pneumonia was estimated
using flow cytometric analyses (Figure 1A). Labeling neutro-





) control antibody yielded less than one-tenth the




mean channel fluorescence [MCF]) observed with the anti–




did not induce any changes in VLA-4 expression on circulat-
ing neutrophils, but surprisingly, the neutrophils that emi-
grated into the BAL fluid in these same mice expressed less




 0.05). In unin-
fected CD18-deficient mice, the circulating neutrophils ex-








induced a further decrease in VLA-4 expression on circulating




 0.05), but no additional de-
crease occurred upon migration of these neutrophils into the
alveolar space (Figure 1A). There was no significant differ-
ence in VLA-4 expression on BAL neutrophils between WT
and CD18-deficient mice.
Because VLA-4 expression on circulating neutrophils was de-
creased in CD18-deficient mice compared with WT mice without
experimental infection, we compared the expression of VLA-4
on the bone marrow neutrophils. However, no difference in
VLA-4 expression was observed (Figure 1B). Circulating neutro-
phils from these same CD18-deficient mice expressed less VLA-4
than those in the bone marrow (and less than circulating neutro-
phils from WT mice, confirming the observations in Figure 1A),
whereas no decrease in VLA-4 was observed in circulating neu-
trophils compared with bone marrow neutrophils in WT mice.
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Gene Expression of VCAM-1 during Bacterial Pneumonia
 
Gene expression of VCAM-1, a ligand of VLA-4, was esti-
mated in murine lungs with and without pneumonia using RT-
PCR at 4 hours after instillation of organisms (Table 1). Total
RNA was isolated from lung homogenates using RNAzol B
(Tel-Test, Friendswood, TX) and reverse transcribed, and the
products were amplified using either of two sets of specific





plified in separate reactions to control for RNA content. PCR
products were revealed by ethidium bromide staining and
quantified by densitometry.
VCAM-1 was amplified using two sets of primer pairs, both
of which amplify the extracellular region of VCAM-1. Primer
pair A amplified mRNA that coded for a portion of Ig domain
2 through domains 3–5. Primer pair B amplified mRNA cod-
ing for regions near the carboxyl terminus including the signal
peptide, Ig domain 1, and part of domain 2. Both sets of
primer pairs gave a single PCR product of the expected size













 0.01), no matter which primer set
was used. RT-PCR using primer set A showed increased










RT-PCR using primer set B showed increased VCAM-1




 pneumonia (Table 1).
 
Localization of VCAM-1 Protein Expression
 
Immunohistochemistry was performed to localize VCAM-1 ex-
pression as previously described (25) using either the rat anti–
VCAM-1 429 monoclonal antibody (Endogen) or rat IgG and
Figure 1. (A) VLA-4 expression on neutrophils obtained
from blood or BAL fluid in uninfected mice or mice
with S. pneumoniae–induced pneumonia for 6 hours.
For flow cytometric analyses, heparinized blood was
taken from the inferior vena cava, and erythrocytes
were hypotonically lysed. Blood and BAL leukocytes
were washed with fresh PBS–EDTA. Cells were stained
with saturating concentrations of a FITC-conjugated
mAb against murine VLA-4 (R1-2; PharMingen) and a
PE-conjugated mAb against the murine granulocyte
marker Gr-1 (RB6-8C5; PharMingen) as previously de-
scribed (28). Cells were then fixed with PBS containing
1% paraformaldehyde. Neutrophils were gated on a
two-dimensional forward and side scattergram of the
Coulter ELITE flow cytometer (Coulter Co., Miami, FL). Gr-1 bright cells had forward and side scatter characteristics consistent with granulocytes.
The fluorescence intensity was measured for each sample by scoring 5,000 Gr-1 bright cells. The VLA-4 expression of neutrophils was represented
by the mean channel fluorescence of 5,000 cells. The MCF values obtained when neutrophils from either WT or CD18-null mice were labeled with
the isotype (rat IgG2b,) control antibody ranged from undetectable to 0.2 MCF. In WT mice, VLA-4 expression was similar on neutrophils from
the blood in uninfected (open bars) and S. pneumoniae–infected (closed bars) mice, whereas neutrophils that had emigrated in the alveolar spaces
expressed less VLA-4 (shaded bars). CD18-deficient mice had significantly less VLA-4 expressed on circulating neutrophils with or without infection
by S. pneumoniae when compared with WT mice. Emigration into the alveolar spaces did not induce a further reduction. n 	 3 in each group.
*p  0.05 compared with blood from mice with S. pneumoniae pneumonia. #p  0.05 compared with blood from uninfected mice. 
p  0.05
compared with WT mice of comparable group. (B) VLA-4 expression on neutrophils obtained from bone marrow or peripheral blood from mice
without experimentally induced pneumonia. For flow cytometry analyses, bone marrow cells were collected by flushing the bone marrow cavity
with 1.0 ml of PBS containing 0.6 mM EDTA. Blood and bone marrow cells were stained as described in A. VLA-4 expression on neutrophils from
the bone marrow was similar in CD18-deficient and WT mice. Open bars: bone marrow. Closed bars: blood. n 	 3 in each group. *p  0.05 com-
pared with bone marrow.
 
TABLE 2. VCAM-1 PROTEIN EXPRESSION ON ARTERIOLES AND








































Immunohistochemistry was performed to localize VCAM-1 expression in mice with-








 pneumonias for 6 hours as previoulsy de-




m were cut, fixed, blocked with
avidin followed by biotin and goat IgG, in methanol: acetone (1:1), and incubated
with either rat anti–VCAM-1 monoclonal antibody (Clone #429; PharMingen) or rat
IgG. After washing, the sections were incubated with biotinylated goat anti-rat IgG
polyclonal antibody, followed by streptavidin-labeled alkaline phosphatase. The com-
plexes were identified by incubating with a substrate combined with new fuchsin. After












). VCAM-1 expression on arterioles and venules was
quantitated by counting the number of vessels that stained either brightly or lightly






TABLE 1. VCAM-1 GENE EXPRESSION
Primer Set
Relative Intensity
Uninfected Streptococcus pneumoniae Escherichia coli
A 1.00  0.05 4.51  0.15* 11.69  0.61*†
B 1.00  0.07 1.28  0.19 9.53  0.77*†
Anesthetized C57BL/6 mice received intratracheal instillation of bacterial suspension
(50 l/22 g of body weight) containing S. pneumoniae (5.4  108 CFU/ml) or E. coli
(1.1  108 CFU/ml) for 4 hours. Lungs were frozen immediately in liquid nitrogen and
stored at 80°C until total RNA extractions were performed. Total RNA was isolated
from lung homogenates (Polytron aggregate; Kinematica, Lucerne, Switzerland) using
RNAzol B (Tel-Test, Friendswood, TX) following manufacturer’s instructions. RNA con-
centrations were determined by spectrophotometric absorption at 260 nm. Total RNA
(2.5 g) was reverse transcribed with 200 U of Moloney murine leukemia virus reverse
transcriptase and 500 ng of oligo(dT)12-18 primer (Gibco BRL, Gaithersburg, MD).
The reverse transcribed products (1 l) were amplified using two sets of specific prim-
ers (A and B) for mouse VCAM-1 (29). Both sets of primers represent an extracellular
region of VCAM-1. -Actin was used as a housekeeping gene. The PCR amplifications
were perfomed in a 50 l reaction volume containing 10 mM Tris–HC1 (pH 9.0), 50
mM KCl, 1.5 mM MgCl2, 0.2 mM dNTPs, and 1.5 U of Taq polymerase (Pharmacia
Biotech, Piscataway, NJ) in PTC-100TM programmable thermal controller (MJ Re-
search, Inc., Watertown, MA) under conditions determined in earlier experiments to be
optimal for exponential amplification. In most experiments, cycling profiles included
an initial denaturation at 94°C, 5 minutes; 5 minutes annealing at 60°C; followed by
35 cycles of 94°C for 45 seconds, 60°C for 45 seconds, and 72°C for 90 seconds for de-
naturing, annealing, and extension, respectively. The cycling was completed with a fi-
nal incubation at 72°C for 10 minutes. The primers used were as follows: VCAM-1,
primer pair A: sense, 5-CAA CGA TCT CTG TAC ATC CC-3; antisense, 5-AGA GGC
TGT ACA CTC TGC CT-3. VCAM-1, primer pair B: sense, 5-AAG GAT CCG GTA CCA
AGC AGA GAC TTG AAA TGC C-3; antisense, 5-CCC TTG AAC AGA TCA ATC TCC-3.
-Actin: sense, 5-GTG GGC CGC TCT AGG CAG-3; antisense, 5-CTT TGA TGT CAC
GCA TTT C-3. Amplified DNAs were resolved by means of agarose gel electrophoresis
and stained with ethidium bromide. Polaroid photographs with ultraviolet exposure
were taken, and the images were converted into numerical data by quantitative densi-
tometry with Scion ImagePC software (Scion, Frederick, MD).
* p  0.01 compared with uninfected control.
† p  0.01 compared with S. pneumoniae pneumonia.
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a streptavidin–alkaline phosphatase detection system. VCAM-1
expression on capillaries, arteries, and veins was evaluated at
600 magnification. Expression on arterioles and venules was
quantitated by counting the number of vessels that stained ei-
ther brightly or lightly per 10 fields at 200 magnification.
In uninfected lungs, VCAM-1 was detectable only on arte-
rial and venous endothelium. No capillary endothelium ex-
pressed VCAM-1. Neither S. pneumoniae nor E. coli induced
VCAM-1 expression on the capillary endothelium within 6
hours. In addition, neither organism induced an increase in
staining on the arteriolar or the venular endothelium (Table
2). Many of these small vessels and virtually all the larger ves-
sels stained brightly, making an increase hard to detect.
Effect of Anti–VLA-4 mAb on Acute Inflammation
during Pneumonia
These studies used the blocking rat anti-mouse VLA-4 mono-
clonal antibody PS/2, a well-described antibody that has been
used previously in vivo to block VLA-4–mediated responses.
For example, this antibody protects against contact hypersen-
sitivity to 2,4-dinitrofluorobenzene or oxazolone (29, 30), in-
hibits ovalbumin delayed-type hypersensitivity (30), induces
immunosuppression to cardiac allografts and soluble antigens
(31), inhibits eosinophil recruitment in ovalbumin-sensitized
and challenged lungs (31) and in allergic conjunctivitis (33),
and prevents mast cell emigration into the intestine in response
to the nemotode Trichinella spiralis (34). After pretreatment
with anti-CD18 antibody and either the anti–VLA-4 antibody
PS/2 or nonspecific rat IgG, C57BL/6 mice were given intratra-
cheal instillations of either S. pneumoniae or E. coli. Edema
and neutrophil emigration were evaluated 6 hours later. Edema
formation was measured by quantitating the accumulation of
extravascular albumin using 125I-labeled and 51Cr-labeled red
blood cells (RBC) as previously described (23, 25–27) and ex-
pressed as microliters per gram bw. Emigrated neutrophils
were quantified by morphometry in histologic sections of car-
bon black–containing lung regions using point counting tech-
niques as previously described (23, 25, 26) and expressed as
the fraction of distal lung tissue that was occupied by intra-
alveolar (emigrated) neutrophils.
Blockade of VLA-4 by PS/2 had no significant effect on the
CD18-independent component of neutrophil emigration in-
duced by either S. pneumoniae or E. coli (Figure 2). Similarly,
blockade of VLA-4 had no effect on the formation of pulmo-
nary edema during S. pneumoniae or E. coli pneumonia (Fig-
ure 3).
Circulating leukocyte and neutrophil counts in blood sam-
ples obtained from the inferior vena cava are shown in Table
3. The leukocyte and neutrophil counts were greater in mice
pretreated with both anti-CD18 and anti–VLA-4 mAb than in
mice pretreated with only the anti-CD18 mAb after 6 hours E.
coli pneumonia (p  0.05). The anti–VLA-4 mAb did not in-
duce a significant difference in leukocyte or neutrophil count
in S. pneumoniae pneumonia.
Effect of Anti–VLA-4 mAb on CD18-Deficient
Neutrophil Emigration
To further evaluate the role of VLA-4 in CD18-independent
neutrophil emigration, a second approach was taken where
mice with bone marrows producing both CD18-deficient and
WT neutrophils were treated with the anti–VLA-4 mAb. This
approach is more likely to detect a small contribution of VLA-4
because the emigration of CD18-null and WT neutrophils are
compared in the same pneumonia within one mouse, so that
the physiologic parameters and the inflammatory milieu are
identical for cells of each genotype. The hematopoietic sys-
tems of lethally irradiated C57BL/6 host mice were reconsti-
tuted by injection of a mixture of CD18-deficient (20%) and
WT (80%) 14-day fetal liver cells as previously described (22).
At least 2 weeks after cessation of antibiotics, pneumonia was
induced by intratracheal instillation of S. pneumoniae (50 l/
22 g bw of a suspension containing 1.1  108 CFU/ml). Mice
received intravenous injection of either rat IgG (4 mg/kg) or
Figure 2. Neutrophil emigration into the alveolar spaces in mice with
6-hour S. pneumoniae or E. coli pneumonia. Mice received an intrave-
nous injection of anti-CD18 antibody and either rat IgG (open bars) or
anti–VLA-4 mAb (closed bars) 15 minutes before instillation of the or-
ganisms. After 6 hours, the lungs were removed and fixed using in-
tratracheal instillation of 6% glutaraldehyde at 22 cm H2O. Emigrated
neutrophils were quantified by morphometry in histologic sections
(23). Carbon black–containing lung regions were embedded in paraf-
fin, and 5- to 7-m thick sections were cut and stained with hematox-
ylin and eosin. A counting grid (10  10, covering 70,000 m2 of the
magnified field) was reflected onto the field of view at 1,000 magni-
fication using a drawing tube. Randomly selected fields of pneumonic
peripheral lung where alveolar macrophages contained carbon parti-
cles were examined. Regions that contained noncapillary blood ves-
sels, bronchioles, or larger airways were not examined. A total of 10
grids (1,000 points) was counted for each lung, and neutrophil emi-
gration was expressed as the fraction of distal lung tissue that was oc-
cupied by intra-alveolar (emigrated) neutrophils. Blockade of VLA-4
did not alter the CD18-independent emigration of neutrophils in re-
sponse to either stimulus. n 	 5 in each group.
Figure 3. Edema formation during 6-hour S. pneumoniae or E. coli pneu-
monia. Mice received an intravenous injection of anti-CD18 antibody
and either rat IgG (open bars) or anti–VLA-4 mAb (closed bars) com-
bined with 125I-labeled human albumin (0.1 Ci/mouse; Mallinckrodt
Medical Inc., Hazelwood, MO) to measure edema. Murine RBC labeled
with 51Cr (0.3 Ci/mouse; DuPont-NEN, Boston, MA) were injected 2
minutes before the end of the study to measure the intravascular blood
volume. At 6 hours, the lungs were removed, blood samples were ob-
tained from the inferior vena cava, and levels of radioactivity were mea-
sured in a  counter. Edema formation in lungs was evaluated by
quantitating the accumulation of extravascular albumin as previously
described (23, 26, 27). Blood and plasma volumes of lungs were de-
termined from 51Cr-RBC and 125I-albumin counts, respectively. Pulmo-
nary edema (extravascular albumin in the lung) was calculated as total
lung albumin content minus intravascular lung albumin content. Intra-
vascular lung albumin content was calculated from the pulmonary
blood volume and the hematocrit for each animal. Pulmonary edema
was expressed as l/g bw. Blockade of VLA-4 did not alter the forma-
tion of edema. n 	 5 in each group.
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anti–VLA-4 mAb (PS/2; 4 mg/kg) 15 minutes before bacterial
instillation. After 6 hours, BAL was performed as described in
Protocol 1. Leukocyte and neutrophil counts in blood and
BAL fluid were determined. The percentage of CD18-defi-
cient neutrophils was assessed for each blood and BAL sam-
ple by scoring 300 neutrophils in cytocentrifuged preparations as
either positive or negative for CD11b/CD18 expression using im-
munocytochemical staining for CD11b (M1/70; PharMingen),
as previously described (22).
In the mice pretreated with rat IgG, the percentage of
CD18-deficient neutrophils did not differ between the circulating
blood and the BAL fluid (Figure 4), indicating that the CD18-
deficient neutrophils showed no defect in emigration toward this
stimulus. In contrast, the percentage of CD18-deficient neu-
trophils was slightly but significantly decreased in the BAL
fluid compared with the circulating blood when the mice were
given PS/2 to block VLA-4 (p  0.01). These observations in-
dicate that the CD18-deficient neutrophils were not able to
migrate as well as the CD18-replete neutrophils when VLA-4
was blocked, suggesting a small but significant role for VLA-4
in CD18-independent emigration. There were no significant
differences between the groups in neutrophil counts in BAL
fluid (rat IgG, 1.36  0.26  106/ml; PS/2, 0.58  0.05  106/ml;
p 	 0.099) or blood (rat IgG, 1.66  0.26  106/ml; PS/2, 1.89 
0.50  106/ml).
DISCUSSION
This study examined the effect of pulmonary infection on
VLA-4 expression in neutrophils and on VCAM-1 expression
in pulmonary endothelial cells, as well as the functional role of
VLA-4 in CD18-independent neutrophil emigration. VLA-4
expression on emigrated neutrophils decreased during S. pneu-
moniae pneumonia. VCAM-1 mRNA was increased many fold
in E. coli pneumonia by 4 hours, but not at all or only slightly
during S. pneumoniae pneumonia. In pneumonia induced by
either organism, VCAM-1 protein expression did not occur on
capillaries, which are the major site of neutrophil emigration
(36–40). Blockade of both VLA-4 and CD18 did not decrease
neutrophil emigration further than blockade of CD18 alone.
More sensitive studies comparing the migration of CD18-defi-
cient neutrophils in mice whose bone marrows were produc-
ing both CD18-deficient and WT neutrophils showed that a
small fraction of CD18-independent neutrophil emigration re-
quired VLA-4. These studies suggest that whereas the inflam-
matory response results in alterations of VLA-4 and VCAM-1
expression, only a very small component of CD18-indepen-
dent adhesion required VLA-4, and VLA-4/CD18-indepen-
dent pathways play an important role in neutrophil emigration
during bacterial pneumonia.
In contrast to the results of Kubes and colleagues (15), we
observed no increase in VLA-4 expression on emigrated neu-
trophils and in fact observed a decrease as compared with cir-
culating neutrophils. Although this could be due to decreased
production of VLA-4, neutrophils have not been found to pro-
duce this molecule after they have left the circulation, making
this possibility unlikely. Alternatively, this molecule may be
cleaved during the inflammatory process, either during the
process of emigration, as suggested by the observations in WT
mice, or while still in the circulation, as suggested by the ob-
servations in CD18-deficient mice. The fact that the CD18-
deficient mice have lower expression of VLA-4 on circulating
neutrophils in the absence of S. pneumoniae does not exclude
an effect of the inflammatory process because these mice have
spontaneous infections as manifested by skin lesions and high
circulating neutrophil counts (23, 24). The observation that
the expression of VLA-4 on bone marrow neutrophils was
similar in CD18-deficient and WT mice indicates that the re-
duction in VLA-4 expression on circulating neutrophils in
CD18-deficient mice was not a direct effect of deletion of
CD18 gene transcription.
In the present study, the addition of anti–VLA-4 mAb to
anti-CD18 mAb failed to further inhibit neutrophil emigration
during E. coli and S. pneumoniae pneumonias. Thus, blocking
TABLE 3. CIRCULATING LEUKOCYTE AND NEUTROPHIL COUNTS
DURING BACTERIAL PNEUMONIA
Leukocytes ( 106/ml) Neutrophils ( 106/ml)
Rat IgG PS/2 Rat IgG PS/2
Streptococcus pneumoniae 2.76  0.44 1.96  0.40 1.62  0.22 0.99  0.18
Escherichia coli 1.47  0.26 4.06  0.49* 0.43  0.06 0.97  0.05*
White blood cells were counted using a hemocytometer, and differentials were de-
termined using blood smears stained with Leukostat (Fischer Scientific, Pittsburgh, PA).
In mice with S. pneumoniae pneumonia, PS/2 administration had no significant effects
on the circulating leukocyte and neutrophil counts in blood samples from the inferior
vena cava obtained 6 hours after instillation. In contrast, both leukocyte and neutrophil
counts were greater in PS/2-treated mice than in mice given rat IgG at 6 hours after in-
stillation of E. coli.
* p  0.05.
Values are means  SEM, n 	 5.
Figure 4. Percentage of
CD18-deficient neutrophils
in blood and BAL fluid ob-




6 host mice were reconsti-
tuted by injection of a mix-
ture of CD18-deficient and
WT fetal liver cells as previ-
ously described (22). CD18-
deficient mice and WT mice of the similar randomly mixed genetic
background (C57BL/6  129/Sv) were mated with the like genotype,
and fetuses were collected at 14 days of gestation. Single-cell suspen-
sions were prepared from WT and CD18-deficient fetal livers, and mix-
tures (20% CD18-deficient; 80% WT) of 2  106 total cells were in-
jected intravenously into host mice that had received radiation doses
of 800 and 400 rad, separated by 3 hours, from a 137Cs source. After
transplantation, mice received trimethoprim–sulfamethoxazole in their
drinking water for 4 weeks and were housed in a full barrier. At least 2
weeks after cessation of antibiotics, pneumonia was induced with S. pneu-
moniae (1.1  108 CFU/ml) as described previously. Mice received in-
travenous injection of either rat IgG (4 mg/kg, squares) or anti–VLA-4
mAb (PS/2; 4 mg/kg, circles) 15 minutes before bacterial instillation.
After 6 hours, BAL was performed. Heparinized blood was obtained
from the inferior vena cava, and erythrocytes were hypotonically lysed.
Blood and BAL leukocytes were washed with fresh PBS–EDTA. Leuko-
cytes and neutrophil counts in blood and BAL fluid were determined.
For immunohistochemical analyses, blood and BAL cells were cytocen-
trifuged onto glass slides, allowed to air dry, and then fixed with ace-
tone:methanol (1:1). Slides were treated with biotinylated rat mAb
against murine CD11b (M1/70; PharMingen), and M1/70 was visual-
ized using a streptavidin–alkaline phosphatase detection system. Con-
trol slides demonstrated no staining of cells when nonspecific rat IgG
replaced M1/70. Slides were counterstained with hematoxylin, and
the percentage of CD18-deficient neutrophils was assessed for each
sample by scoring 300 polymorphonuclear cells as either positive or
negative for CD11b/CD18 expression (22). The data show that the
percentage of CD18-deficient neutrophils in the blood and the BAL
fluid was similar when the function of VLA-4 was not inhibited. Block-
ade of VLA-4 did induce a small but significant decrease in the emigra-
tion of CD18-deficient cells. n 	 5 in each group. *p  0.05 compared
with peripheral blood. Squares: mice treated with anti–VLA-4 antibody
15 minutes before instillation of organisms. Circles: mice pretreated
with rat IgG (control animals).
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VLA-4 did not inhibit the CD18-independent component of
neutrophil emigration in either E. coli pneumonia, where the
CD18-independent component comprises only 30% of emigra-
tion, or in S. pneumoniae pneumonia, where all neutrophil em-
igration occurs through CD18-independent pathways. In addi-
tion to mediating the adhesion and emigration of circulating
leukocytes, VLA-4 may contribute to other local and systemic
responses to inflammatory stimuli. For example, studies by
Henderson and colleagues (41) demonstrated in an airway hy-
persensitivity study that VLA-4 was required for cytokine re-
lease in the lungs. In the present studies, intravenous adminis-
tration of blocking VLA-4 antibodies had no effect on edema
accumulation during either E. coli or S. pneumoniae pneumo-
nias. These data suggest that VLA-4–mediated cell interactions
are not required for the signaling events resulting in local
plasma extravasation.
Because the role of VLA-4 might be too small to measure dif-
ferences in these complex parameters of inflammation, studies
were performed using mice whose bone marrows expressed both
CD18-deficient and WT neutrophils. This approach will likely
detect a subtler role for VLA-4 in neutrophil emigration, partly
because each mouse serves as its own control and the CD18
null and WT genotypes can be compared in the same hemody-
namics and inflammatory milieu. The percentages of CD18-
deficient neutrophils in the circulating and emigrated pools
were compared during S. pneumoniae pneumonia. In mice pre-
treated with rat IgG, similar percentages of CD18-deficient
neutrophils were observed in the blood and BAL fluid 6 hours
after intratracheal instillation of S. pneumoniae, indicating that
neutrophil emigration induced by S. pneumoniae was CD18-
independent. This observation is consistent with our previous
experiments, which also revealed that the percentage of CD18-
deficient neutrophils in the BAL fluid was significantly smaller
than in the peripheral blood in E. coli LPS pneumonia, a stim-
ulus known to elicit CD18-dependent neutrophil emigration
(6, 7, 22).
However, in mice pretreated with anti–VLA-4 mAb, the
percentage of CD18-deficient neutrophils in BAL neutrophils
was significantly lower than the percentage in circulating neu-
trophils, suggesting that emigration of the CD18-deficient popu-
lation was partially blocked by the anti–VLA-4 mAb. These data
suggest that a small portion of CD18-independent emigration
may be mediated through VLA-4, but at least one CD18- and
VLA-4–independent pathway of neutrophil emigration exists
and is functional in the lungs. An alternative explanation might
be that CD18-null neutrophils use alternative pathways that
are partially mediated by VLA-4, whereas WT neutrophils do
not. In fact, observations in CD18-null mice support usage of
alternative pathways (23, 25). However, these reconstituted mice
have a large fraction of WT neutrophils that prevent the neu-
trophilia, the extramedullary hematopoiesis, infectious skin ul-
cerations, and other aspects of the CD18 null phenotype (23,
24, 42), making the use of alternative pathways by the CD18-
null neutrophils less likely. Furthermore, there was no increase in
VLA-4 expression in CD18-null neutrophils (Figure 1B). There-
fore, we interpret these data to suggest that a small fraction of
CD18-independent emigration in WT mice may occur through
VLA-4–mediated pathways, but CD18-independent, VLA-4–
independent pathways clearly contribute.
These observations are consistent with those of Li and col-
leagues (43), who demonstrated that LPS-induced neutrophil
emigration at later (18 hours) time points was partially inhib-
ited by about 30% when rats were pretreated with antibodies
against both CD18 and VLA-4. Previous reports also sug-
gested that blocking VLA-4 during adjuvant-induced arthritis
did not completely inhibit CD18-independent neutrophil emi-
gration, although the contribution of VLA-4 appeared larger
than in the lungs (17, 19). The studies by Ridger and col-
leagues (20) and by Burns and colleagues (21) both demon-
strate a larger role for VLA-4 in CD18-independent emigra-
tion in response to KC and to LPS, respectively, compared with
our studies of E. coli– and S. pneumoniae–induced emigration.
However, both studies clearly show a component of emigra-
tion that does not require CD11/CD18 or VLA-4, and mea-
sures about 30% of KC-induced neutrophil emigration (20) and
about 40% of LPS-induced emigration (21). Furthermore, the
studies by Ridger and colleagues suggest that the role VLA-4
is playing is not in neutrophil–endothelial adhesion but rather
in neutrophil emigration through the interstitium, leading to
the postulate that VLA-4–fibronectin interactions contribute
to neutrophil emigration (20). Taken together, all these studies
suggest that the adhesion molecules mediating CD11/CD18-
independent interactions between neutrophils and pulmonary
capillary endothelial cells remain unclear. In addition, the
roles of VLA-4 in mediating either neutrophil–matrix or neu-
trophil–endothelial cells depend on the inflammatory stimu-
lus. We are particularly interested in these bacterial stimuli, as
they represent clinically important, albeit complex, pathogens.
At 4 hours after instillation of organisms, VCAM-1 gene
expression as evaluated using RT-PCR appeared greater in E.
coli pneumonia, which elicits CD18-dependent emigration,
than in S. pneumoniae pneumonia, which elicits CD18-inde-
pendent emigration. This result is compatible with a previous
report describing increased production of VCAM-1 on endo-
thelial cells by IL-1 or TNF- as early as 4 hours (44, 45). E.
coli induces production of IL-1 and TNF-, as well as the ex-
pression of ICAM-1 on the pulmonary capillary endothelium
(46). Immunohistochemistry demonstrated that the endothe-
lial cells producing VCAM-1 were not lining capillaries, the
major site of neutrophil emigration (36–40). In fact, the immu-
nohistochemistry did not demonstrate any site of increased
protein production. Arteries, arterioles, venules, and veins
showed VCAM-1 expression in uninfected murine lungs, and
the highly sensitive but nonquantitative nature of immunohis-
tochemistry may preclude detection of an increase at these
sites. Alternatively, the increased transcription observed by
RT-PCR may not lead to increased VCAM-1 protein expres-
sion. In light of the absence of VCAM-1 expression by the
capillaries, the lack of a functional role for VLA-4 in acute
neutrophil emigration is not surprising, and the small role ob-
served in S. pneumoniae pneumonia may be due to a require-
ment for this molecule in the rolling or adhesion of the few
neutrophils that migrate through arterioles or venules. This in-
creased VCAM-1 mRNA may also function later in the course
of the pneumonia, perhaps in the recruitment of monocytes or
lymphocytes.
CD18-deficient mice have 5- to 30-fold increases in circu-
lating neutrophil counts and 3- to 5-fold increases in neutro-
phil emigration during pneumonia (23, 24). The molecules medi-
ating this emigration remain enigmatic. The decrease in VLA-4
expression on circulating neutrophils in CD18-deficient mice
compared with WT suggests that VLA-4 is not compensating
for the deficiency of CD18. This conclusion is also supported by
the lack of an increase in VLA-4 expression in neutrophils within
the bone marrow. Finally, the data addressing the function of
this molecule suggest that VLA-4 mediates only a small fraction
of CD18-independent adhesion, although no studies were per-
formed in CD18-deficient mice to directly test this hypothesis.
In summary, these studies show that the expression of
VLA-4 on neutrophils is decreased during CD18-independent
emigration induced by S. pneumoniae, that VCAM-1 is not
upregulated on pulmonary capillaries in S. pneumoniae or E.
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coli pneumonia, and that VLA-4-mediated adhesion accounts
for only a small fraction of neutrophils that emigrate through
CD18-independent pathways. The molecules that mediate
CD18-independent, VLA-4–independent neutrophil emigra-
tion remain to be determined.
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